The informative and persuasive components of pharmaceutical promotion - An argument for why the two can coexist

International Journal of Advertising

Volumn 28, Issue 2, 2009, Pages

  Rod, Michel ^a   Saunders, Sarena ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69549116624     PISSN: 02650487     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (119)

1. Alperstein, N.M. & Peyrot, M. (1993) Consumer awareness of prescription drug advertising. Journal of Advertising Research, 33(4), pp. 50-56.
2. Anand, P. & Sternthal, B. (1989) Strategies for designing persuasive messages: deductions from the resource matching hypothesis, in Cafferata, P. & Tybout, A. (eds) Cognitive and Affective Responses to Advertising. Lexington, MA: The Free Press, pp. 135-159.
3. Andaleeb, S.S. & Tallman, R.F. (1995) Physician attitudes toward pharmaceutical sales representatives. Health Care Management Review, 20(3), pp. 68-76.
4. Andersen, P. (2001) Relationship development and marketing communication: an integrative model. Journal of Business & Industrial Marketing, 16(3), pp. 167-182.
5. Auton, F. (2004) The advertising of pharmaceuticals direct to consumers: a critical review of the literature debate. International Journal of Advertising, 23(1), pp. 5-52.
6. Bauer, R. & Wortzel, L.H. (1966) Doctor's choice: the physician and his sources of information about drugs. Journal of Marketing Research, 3(1), pp. 40-47.
7. Bleidt, B. (1992) Marketing activities: the keystone of capitalism - increasing the availability of prescription drugs through pharmaceutical promotion. Journal of Drug Issues, 22(2), pp. 277-293.
8. Burnkrant, R.E & Sawyer, A.G. (1983) Effects of involvement and message content on information processing intensity, in Harris, R.J. (ed.) Information Processing Research in Advertising. Hillsdale, NJ: Lawrence Erlbaum Associates.
9. Calfee, J.E. (2002) Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing, 21(2), pp. 174-193.
10. Campbell, E.G. (2007) A national survey of physician-industry relationships. New England Journal of Medicine, 357(18), p. 1796.
11. Canadian Pharmacists Association (1996) Guidelines on the ethics of relationships between pharmacists & pharmaceutical manufacturers, http://www.pharmacists.ca/content/about_cpha/who_we_are/policy_position/policy.cfm?policy_id=6.
12. Capon, N., Farley, J.U. & Hoenig, S. (1990) Determinants of financial performance: a meta-analysis. Management Science, 36(10), pp. 1143-1159.
13. Chambliss, M.L. (1994) Is pharmaceutical marketing valuable? Archives of Family Medicine, 3(12), pp. 1032-1033.
14. Chattopadhyay, A. & Alba, J.W. (1988) The situational importance of recall and inference in consumer decision making. Journal of Consumer Research, 15(1), pp. 1-12.
15. Choi, S.M. & Lee, W.-N. (2007) Understanding the impact of direct-to-consumer (DTC) pharmaceutical advertising on patient-physician interactions. Journal of Advertising, 36(3), pp. 137-149.
16. Christy, R., Oliver, G. & Penn, J. (1996) Relationship marketing in consumer markets. Journal of Marketing Management, 12(1-3), pp. 175-187.
17. Cialdini, R.B. (1993) Influence: Science and Practice (3rd edn). New York: HarperCollins.
18. Cialdini, R.B. (1999) Of tricks and tumors: some little-recognized costs of dishonest use of effective social influence. Psychology & Marketing, 16(2), pp. 91-98.
19. Cialdini, R.B. (2001) Harnessing the science of persuasion. Harvard Business Review, 79(9), pp. 72-79.
20. Cohen, J.B. (2002) Introductory comments: direct-to-consumer prescription drug advertising: evaluating regulatory policy in the United States and New Zealand. Journal of Public Policy & Marketing, 21(2), pp. 172-173.
21. Coney, S. (2002) Direct-to-consumer advertising of prescription pharmaceuticals: a consumer perspective from New Zealand. Journal of Public Policy & Marketing, 21(2), pp. 213-223.
22. Corstjens, M. (1991) Marketing Strategy in the Pharmaceutical Industry. London: Chapman & Hall.
23. Crigger, N.J. (2005) Pharmaceutical promotions and conflict of interest in nurse practitioner's decision-making: the undiscovered country. Journal of the American Academy of Nurse Practitioners, 16(6), pp. 207-212.
24. Deamer, R.L. (1994) Value and need for pharmaceutical promotion disputed. Archives of Family Medicine, 3(12), p. 1033.
25. DeLorme, D., Huh, J. & Reid, L. (2006) Perceived effects of direct-to-consumer (DTC) prescription drug advertising on self and others. Journal of Advertising, 35(3), pp. 47-65.
26. Dickinson, J.G. (1992) Kessler targets Merck-Medco, et al., Medical Marketing & Media, pp. 86-88.
27. Dickinson, J.G. (1995) FDA states its case. Medical Marketing & Media, pp. 56-57.
28. Donaldson, B., Tzokas, N. & Saren, M. (2001) The sales never closes: how closer relationships between buyers and sellers change the role of the salesperson. Journal of Selling and Major Account Management, 3(2), pp. 31-43.
29. Donohue, J.M., Cevasco, M. & Rosenthal, M.B. (2007) A decade of direct-to-consumer advertising of prescription drugs. New England Journal of Medicine, 57(7), pp. 673-681.
30. Eagle, L. & Chamberlain, K. (2004) Prescription medication advertising: professional discomfort and potential patient benefits - can the two be balanced? International Journal of Advertising, 23(1), pp. 69-90.
31. Fazio, R.H. (1990) Multiple processes by which attitudes guide behaviour: the mode model as an integrative framework, in Zanna, M.P. (ed.) Advances in Experimental Psychology, 23(1). New York: Academic Press, pp. 75-109.
32. Fisher, M.A. (2003) Physicians and the pharmaceutical industry - a dysfunctional relationship. Perspectives in Biology and Medicine, 46(2), pp. 254-272.
33. Foss, K. (2001) Drug firms' freebies entice doctors. Globe and Mail, Toronto, 2 January.
34. Friedman, M. & Gould, J. (2007) Consumer attitudes and behaviors associated with direct-to-consumer prescription drug marketing. Journal of Consumer Marketing, 24(2), pp. 100-109.
35. Friestad, M. & Wright, P. (1994) The persuasion knowledge model: how people cope with persuasion attempts. Journal of Consumer Research, 21(1), pp. 1-31.
36. Gagnon, M.-A. & Lexchin, J. (2008) The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the united states. PLoS Medicine, 5(1), pp. 29-33.
37. Gatignon, H. & Hanssens, D.M. (1987) Modelling marketing interactions with application to sales force effectiveness. Journal of Marketing Research, 24(3), pp. 247-257.
38. Goldstein, A.O. & Ives, T.J. (1994) Pharmacoeconomic considerations in pharmaceutical company promotions. Archives of Family Medicine, 3(12), p. 1034.
39. Grönroos, C. (1990) Relationship approach to marketing in service contexts: the marketing and organizational behaviour interface. Journal of Business Research, 20 (1), pp. 3-11.
40. Grönroos, C. (1994) From marketing mix to relationship marketing: towards a paradigm shift in marketing. Management Decision, 32(2), pp. 4-20.
41. Harker, M. & Harker, D. (2007) Direct-to-consumer advertising of prescription medicines: a systematic review of the evidence from the perspective of the consumer. Journal of Medical Marketing, 7(1), pp. 45-54.
42. Henry, D. & Lexchin, J. (2002) The pharmaceutical industry as a medicines provider. The Lancet, 360(9345), pp. 1590-1595.
43. Hirschman, E.C. (1987) People as products: analysis of a complex marketing exchange. Journal of Marketing, 51(1), pp. 98-108.
44. Hoek, J. & Gendall, P. (2002) Direct-to-consumer advertising down under: an alternative perspective and regulatory framework. Journal of Public Policy & Marketing, 21(2), pp. 202-212.
45. Hoek, J., Gendall, P. & Calfee, J. (2004) Direct-to-consumer advertising of prescription medicines in the united states and New Zealand: an analysis of regulatory approaches and consumer responses. International Journal of Advertising 23(2), pp. 197-228.
46. Holmer, A.F. (1999) Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA, 281(4), pp. 380-382.
47. Huh, J. & Becker, L.B. (2005) Direct-to-consumer prescription drug advertising: understanding its consequences. International Journal of Advertising, 24(4), pp. 441-466.
48. Huh, J. & Langteau, R. (2007) Presumed influence of direct-to-consumer (DTC) prescription drug advertising on patients. Journal of Advertising, 36(3), pp. 151-172.
49. Huh, J., DeLorme, D. & Reid, L. (2004) The information utility of DTCA prescription drug advertising. Journalism and Mass Communication Quarterly, 81(4), pp. 788-807.
50. Jancic, Z. & Zabkar, V. (2002) Impersonal vs personal changes on marketing relationships. Journal of Marketing Management, 18(7/8), pp. 657-671.
51. Kessler, D.A. (1991) Drug promotion and scientific exchange. New England Journal of Medicine, 325(3), pp. 201-203.
52. Lee, B., Salmon, C.T. & Paek, H.-J. (2007) The effects of information sources on consumer reactions to direct-to-consumer (DTC) prescription drug advertising. Journal of Advertising, 36(1), pp. 107-119.
53. Lerer, L. (2001) The European e-health opportunity: a context for pharmaceutical marketing. International Journal of Medical Marketing, 1(4), pp. 326-339.
54. Lerer, L. (2002) Pharmaceutical marketing segmentation in the age of the internet. International Journal of Medical Marketing, 2(2), pp. 159-166.
55. Levitt, T. (1983) After the sale is over. Harvard Business Review, 61(5), pp. 87-93.
56. Levy, R. (1994a) The role and value of pharmaceutical marketing. Archives of Family Medicine, 3(4), pp. 327-332.
57. Levy, R. (1994b) In reply. Archives of Family Medicine, 3(12), p. 1035.
58. Lexchin, J. (1994) Canadian marketing codes: how well are they controlling pharmaceutical promotion? International Journal of Health Services, 24(1), pp. 91-104.
59. Lexchin, J. & Mintzes, B. (2002) Direct-to-consumer advertising of prescription drugs: the evidence says no. Journal of Public Policy & Marketing, 21(2), pp. 194-201.
60. Lloyd, C. & Newell, H. (2001) Capture and transfer: improving the performance of the pharmaceutical sales rep. International Journal of Human Resource Management, 12(3), pp. 464-483.
61. Main, K.J., Argo, J.J. & Huhmann, B.A. (2004) Pharmaceutical advertising in the USA: information or influence? International Journal of Advertising, 23(1), pp. 119-135.
62. Marshall, C. & Rossman, G.B. (1995) Designing Qualitative Research. Thousand Oaks, CA: Sage.
63. McKechnie, S. (1999) Health on the internet: a mixed blessing. Consumer Policy Review, 9(3), pp. 86-91.
64. Mehta, A. & Purvis, S.C. (2003) Consumer response to print prescription drug advertising. Journal of Advertising Research, 43(2), pp. 194-206.
65. Menon, A., Deshpande, A., Perri III, M. & Zinkhan, G. (2004) A model assessing the effectiveness of direct-to-consumer advertising: integration of concepts and measures from marketing and healthcare. International Journal of Advertising, 23(1), pp. 91-118.
66. Metzl, J.M. (2007) If direct-to-consumer advertisements come to Europe: lessons from the USA. Lancet, 369(9588), pp. 704-706.
67. Meyers-Levy, J. & Malaviya, P. (1999) Consumers' processing of persuasive advertisements: an integral framework of persuasion theories. Journal of Marketing, 63, pp. 45-60.
68. Ministry of Health (2006) Direct-to-consumer advertising of prescription medicines in New Zealand: consultation document. Wellington: Ministry of Health, available online at: http://www.moh.govt.nz.
69. Mitzen, E. (1999) Outsourcing pharmaceutical marketing: an emerging industry practice. Pharmaceutical Executive, 19(4), pp. 110-116.
70. Montagne, M. (1992) Drug advertising and promotion: an introduction. Journal of Drug Issues, 22(2), pp. 195-203.
71. Mott, D.A. & Schommer, J.C. (1999) Agency theory, drug formularies, and drug product selection: implications for public policy. Journal of Public Policy & Marketing, 17(2), pp. 287-295.
72. Moynihan, R. (2003a) Drug company sponsorship of education could be replaced at a fraction of its cost. British Medical Journal, 326(7400), p. 1163.
73. Moynihan, R. (2003b) Who pays for the pizza? Redefining the relationships between doctors and drug companies 1: entanglement. British Medical Journal, 326 (7400), pp. 1189-1192.
74. Moynihan, R. (2003c) Who pays for the pizza? Redefining the relationships between doctors and drug companies 2: disentanglement. British Medical Journal, 326 (7400), pp. 1193-1196.
75. Myers, M.J. (1992) Marketing and pharmaceutical development. Journal of Drug Issues, 22(2), pp. 221-234.
76. Narayanan, S., Desiraju, R. & Chintagunta, P.K. (2004) Return on investment implications for pharmaceutical promotional expenditures: the role of marketing mix interactions. Journal of Marketing, 68(4), pp. 90-105.
77. Neslin, S.A. (2001) ROI analysis of pharmaceutical promotions (RAPP): an independent study. Association of Medical Publications, available at http:www.rappstudy.org.
78. Oldani, M. (2004) Thick prescriptions: toward an interpretation of pharmaceutical sales practices. Medical Anthropology Quarterly, 18(3), pp. 325-356.
79. Parker, R.S. & Pettijohn, C.E. (2003) Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: the impact on pharmaceutical sales and physicians. Journal of Business Ethics, 48(3), pp. 279-290.
80. Parsons, P. (2007) Integrating ethics with strategy: analyzing disease-branding. Corporate Communications: An International Journal, 12(3), pp. 267-279.
81. Parvatiyar, A., Sheth, J.N. & Whittington, Jr, F.B. (1992) Paradigm shift in interfirm marketing relationships: emerging research issues. Conference presentation - Customer Relationship Management: Theory and Practice, Emory University, Atlanta, GA.
82. Pathak, D.S., Escovitz, A. & Kucukarslan, S. (1992) Promotion of Pharmaceuticals -Issues, Trends, Options. Binghamton, NY: Pharmaceutical Products Press.
83. Patton, M.Q. (2002) Qualitative Research and Evaluation Methods. Thousand Oaks, CA: Sage.
84. Petroshius, S., Titus, P. & Hatch, K. (1995) Physicians' attitudes towards pharmaceutical drug advertising. Journal of Advertising Research, 35(6), pp. 41-51.
85. Petty, R. & Cacioppo, J. (1986) Communication and Persuasion: Central and Peripheral Routes to Attitude Change. New York: Springer.
86. Peyrot, M., Alperstein, N., Van Doren, D. & Poli, L. (1998) Direct-to-consumer ads can influence behavior. Marketing Health Services, 18(2), pp. 26-32.
87. Pitt, L. & Nel, D. (2001) Pharmaceutical promotion tools - their relative importance. European Journal of Marketing, 22(5), pp. 7-14.
88. Poirier, T., Giannetti, V. & Giudici, R. (1994) Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices. American Journal of Hospital Pharmacy, 51(3), pp. 378-381.
89. Rao, S. (2002) Pharmaceutical marketing in a new age. Marketing Health Services, 22(1), pp. 7-12.
90. Reast, J. & Carson, A. (2000) UK physicians' attitudes towards direct-to-consumer advertising of prescription drugs: an exploratory analysis. International Journal of Advertising, 19(3), pp. 397-415.
91. Reast, J., Palihawadana, D. & Spickett-Jones, G. (2004) UK physicians attitudes towards direct-to-consumer advertising of prescription drugs: an extension and review. International Journal of Advertising, 23(2), pp. 229-251.
92. Reekie, D. (1970) Some problems associated with the marketing of ethical pharmaceutical products. Journal of Industrial Economics, 19(1), pp. 33-49.
93. Relman, A. (2001) Separating continuing medical education from pharmaceutical marketing. JAMA, 285(15), pp. 2009-2012.
94. Robinson, J. (2001) Prescription Games: Money, Ego, and Power Inside the Global Pharmaceutical Industry. London: Simon and Schuster.
95. Roth, M. (2003) Media and message effects on DTCA prescription drug print advertising awareness. Journal of Advertising Research, 43(2), pp. 180-193.
96. Scharitzer, D. & Kollarits, H. (2000) Satisfied customers: profitable customer relationships: pharmaceutical marketing: how pharmaceutical sales representatives can achieve economic success through relationship management with settled general practitioners - an empirical study. Total Quality Management, 11(7), pp. S955-S965.
97. Scott, T., Stanford, D. & Thompson, R. (2004) Killing me softly: myth in pharmaceutical advertising. British Medical Journal, 329(7480), pp. 1484-1487.
98. Shaughnessy, A., Slawson, D. & Bennett, J. (1994) Pharmaceutical advertising: the FDA does not protect us. Archives of Family Medicine, 3(12), p. 1031.
99. Sheth, J. & Parvatiyar, A. (1993) The evolution of relationship marketing. Conference Presentation - Sixth Conference on: Historical Thought in Marketing, Atlanta, GA, pp. 1-34.
100. Sheth, J. & Parvatiyar, A. (1995) The evolution of relationship marketing. International Business Review, 4(4), pp. 397-418.
101. Shin, J. & Moon, S. (2005) Direct to consumer prescription drug advertising: concerns and evidence on consumers' benefit. Journal of Consumer Marketing, 22(7), pp. 397-403.
102. Smith, B. (2004) Making marketing happen: how great medical companies make strategic marketing planning work for them. International Journal of Medical Marketing, 4(2), pp. 129-142.
103. Spake, D. & Joseph, M. (2007) Consumer opinion and effectiveness of direct-to-consumer advertising. Journal of Consumer Marketing, 24(5), pp. 283-292.
104. Spiggle, S. (1994) Analysis and interpretation of qualitative data in consumer research. Journal of Consumer Research, 21(3), pp. 491-503.
105. Stake, R.E. (1993) Case studies, in Denzin, N. & Lincoln, Y. (eds) Handbook of Qualitative Research. Thousand Oaks, CA: Sage.
106. Taylor, P. (1999) Sales force: a review of drug marketing strategies. Consumer Policy Review, 9(1), pp. 14-25.
107. Tengilimoglu, D., Kisa, A. & Ekiyor, A. (2004) The pharmaceutical sales rep/physician relationship in Turkey: ethical issues in an international context. Health Marketing Quarterly, 22(1), pp. 21-39.
108. Thompson, R. (1994) Pharmaceutical marketing. Archives of Family Medicine, 3(12), pp. 1031-1032.
109. Waud, D. (1992) Pharmaceutical promotions - a free lunch? New England Journal of Medicine, 327(5), pp. 351-353.
110. Wazana, A. (2000) Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA, 283(3), pp. 373-380.
111. Webster, F, Jr (1992) The changing role of marketing in the corporation. Journal of Marketing, 56(4), pp. 1-17.
112. Weitz, B. & Bradford, K. (1999) Personal selling and sales management: a relationship marketing perspective. Journal of the Academy of Marketing Science, 27(2), pp. 241-254.
113. White, H., Draves, L., Soong, R. & Moore, C. (2004) Ask your doctor! Measuring the effect of direct-to-consumer communications in the world's largest healthcare market. International Journal of Advertising, 23(1), pp. 53-68.
114. Wilkes, M., Bell, R. & Kravita, R. (2000) Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs, 19(2), pp. 110-128.
115. Williams, J. & Jensel, P. (1995) Direct to consumer advertising of prescription drugs. Journal of Health Care Marketing, 15(1), pp. 35-41.
116. Wittink, D. (2002) Analysis of ROI for pharmaceutical promotions (ARPP). Paper presented to the Association of Medical Publications (18 September), available at http://www.vioworks.com/clients/amp.
117. Wright, P. (1980) Message-evoked thoughts: persuasion research using thought verbalisations. Journal of Consumer Research, 7(2), pp. 151-175.
118. Wright, R. & Lundstrom, W. (2004) Physicians' perceptions of pharmaceutical sales representatives: a model for analysing the customer relationship. International Journal of Medical Marketing, 4(1), pp. 29-38.
119. Yin, R.K. (1994) Applications of Case Study Research. Applied Social Research Methods Series 34. Newbury Park: Sage.